Showing results (51-60 of 164) with videos related to
Sort By:
Pageof 17
Current Medicinal Chemistry|March 8, 2024
Immunotherapy of Human Melanoma: Past, Present, FutureKeywan Mortezaee, Jamal MajidpoorJournal of Cellular Biochemistry|September 28, 2018
Cancer-associated fibroblasts: Secretions, interactions, and therapyBagher Farhood, Masoud Najafi, Keywan MortezaeeMedical Oncology (Northwood, London, England)|September 7, 2022
Epithelial-mesenchymal transition in cancer stemness and heterogeneity: updatedKeywan Mortezaee, Jamal Majidpoor, Ebrahim KharazinejadLife Sciences|October 20, 2022
VISTA immune regulatory effects in bypassing cancer immunotherapy: UpdatedKeywan Mortezaee, Jamal Majidpoor, Sajad NajafiJournal of Cellular Physiology|October 15, 2018
Contribution of regulatory T cells to cancer: A reviewMasoud Najafi, Bagher Farhood, Keywan MortezaeeInternational Immunopharmacology|March 18, 2023
Indoleamine 2,3-dioxygenase 1 in circumventing checkpoint inhibitor responses: UpdatedArian Charehjoo, Jamal Majidpoor, Keywan MortezaeeClinica Chimica Acta; International Journal of Clinical Chemistry|November 25, 2023
Liquid biopsy in colorectal cancerSajad Najafi, Jamal Majidpoor, Keywan MortezaeeInternational Immunopharmacology|July 17, 2023
Dual anti-PD-(L)1/TGF-β inhibitors in cancer immunotherapy - UpdatedZana Karami, Keywan Mortezaee, Jamal MajidpoorLife Sciences|October 29, 2022
The impact of microbiota on PD-1/PD-L1 inhibitor therapy outcomes: A focus on solid tumorsSajad Najafi, Jamal Majidpoor, Keywan MortezaeeJournal of Cellular Biochemistry|October 16, 2018
Extracellular matrix (ECM) stiffness and degradation as cancer driversMasoud Najafi, Bagher Farhood, Keywan MortezaeePageof 17